000 01395 a2200385 4500
005 20250513034104.0
264 0 _c19950822
008 199508s 0 0 eng d
022 _a0014-2980
024 7 _a10.1002/eji.1830250603
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVossen, A C
245 0 0 _aFc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects.
_h[electronic resource]
260 _bEuropean journal of immunology
_cJun 1995
300 _a1492-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCells, Cultured
650 0 4 _aGraft Rejection
_xprevention & control
650 0 4 _aImmunosuppression Therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMuromonab-CD3
_xadverse effects
650 0 4 _aReceptors, Fc
_xmetabolism
650 0 4 _aSkin Transplantation
_ximmunology
650 0 4 _aSpleen
_ximmunology
650 0 4 _aTumor Necrosis Factor-alpha
_xmetabolism
700 1 _aTibbe, G J
700 1 _aKroos, M J
700 1 _avan de Winkel, J G
700 1 _aBenner, R
700 1 _aSavelkoul, H F
773 0 _tEuropean journal of immunology
_gvol. 25
_gno. 6
_gp. 1492-6
856 4 0 _uhttps://doi.org/10.1002/eji.1830250603
_zAvailable from publisher's website
999 _c7614412
_d7614412